International journal of general medicine · 2026
Multi-Omics Identification of Key Immune Molecules in Gestational Diabetes Mellitus: FKBP5 and HLA-DQA1 as Candidate Biomarkers.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Ju, Qin Yuehan, Chen Nuo, Wang Jiao
Аннотация
BACKGROUND: Gestational diabetes mellitus (GDM) is a major metabolic complication of pregnancy in which immune dysregulation has been implicated. The Systemic Immune-Inflammation Index (SII) has been significantly associated with GDM risk, highlighting the importance of the placental immune microenvironment in GDM pathogenesis. Yet comprehensive cross-modality integration of immune molecular data remains limited. This study aimed to systematically identify and validate key placental immune molecules in GDM.
PATIENTS AND METHODS: Bulk transcriptome data (training set: 10 GDM/10 controls; validation set: 32 GDM/31 controls) and single-cell data (4 donors, 2 GDM/2 controls) were obtained from GEO. Differential expression, GO/KEGG enrichment, and ssGSEA-based immune infiltration analyses were performed. Three machine-learning algorithms (LASSO, SVM-RFE, Random Forest) were applied for feature selection, and consensus genes were validated in the independent validation cohort and in clinical samples by qRT-PCR (30 GDM/30 controls). A nomogram model was built and assessed by AUC, calibration curves, the Hosmer-Lemeshow test, and the Brier score. Candidate drugs were identified via CMap, with molecular docking and 100-ns molecular dynamics simulations.
RESULTS: Bulk analysis identified 378 differentially expressed genes (190 up, 188 down) enriched in immune response, cytokine production, and insulin signalling. Three-algorithm consensus nominated CLEC12A, FKBP5 and HLA-DQA1; however, CLEC12A failed to replicate in the independent validation cohort and was therefore not advanced to qRT-PCR. FKBP5 and HLA-DQA1 retained significant downregulation in GDM placentas across the training set, validation set, and clinical samples (qRT-PCR P<0.001). Both genes correlated with immune infiltration patterns including activated B cells. The AUCs in both training and validation sets were modest, indicating preliminary discriminative ability. The nomogram showed acceptable calibration (Hosmer-Lemeshow P=0.342; Brier score=0.118).
CONCLUSION: FKBP5 and HLA-DQA1 are candidate biomarkers with preliminary diagnostic evidence warranting validation in larger multi-centre cohorts.
PATIENTS AND METHODS: Bulk transcriptome data (training set: 10 GDM/10 controls; validation set: 32 GDM/31 controls) and single-cell data (4 donors, 2 GDM/2 controls) were obtained from GEO. Differential expression, GO/KEGG enrichment, and ssGSEA-based immune infiltration analyses were performed. Three machine-learning algorithms (LASSO, SVM-RFE, Random Forest) were applied for feature selection, and consensus genes were validated in the independent validation cohort and in clinical samples by qRT-PCR (30 GDM/30 controls). A nomogram model was built and assessed by AUC, calibration curves, the Hosmer-Lemeshow test, and the Brier score. Candidate drugs were identified via CMap, with molecular docking and 100-ns molecular dynamics simulations.
RESULTS: Bulk analysis identified 378 differentially expressed genes (190 up, 188 down) enriched in immune response, cytokine production, and insulin signalling. Three-algorithm consensus nominated CLEC12A, FKBP5 and HLA-DQA1; however, CLEC12A failed to replicate in the independent validation cohort and was therefore not advanced to qRT-PCR. FKBP5 and HLA-DQA1 retained significant downregulation in GDM placentas across the training set, validation set, and clinical samples (qRT-PCR P<0.001). Both genes correlated with immune infiltration patterns including activated B cells. The AUCs in both training and validation sets were modest, indicating preliminary discriminative ability. The nomogram showed acceptable calibration (Hosmer-Lemeshow P=0.342; Brier score=0.118).
CONCLUSION: FKBP5 and HLA-DQA1 are candidate biomarkers with preliminary diagnostic evidence warranting validation in larger multi-centre cohorts.